{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:22:49Z","timestamp":1770967369226,"version":"3.50.1"},"reference-count":8,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,6,2]]},"DOI":"10.1182\/blood-2016-04-708206","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T17:16:10Z","timestamp":1464887770000},"page":"2661-2662","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":7,"title":["Cytogenetics in CML: more important than you think"],"prefix":"10.1182","volume":"127","author":[{"given":"Fran\u00e7ois","family":"Guilhot","sequence":"first","affiliation":[{"name":"INSERM CLINICAL INVESTIGATION CENTRE 1402"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111904310898400_B1","author":"Wang"},{"issue":"1","key":"2019111904310898400_B2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ijc.2910180105","article-title":"Non-random karyotypic evolution in chronic myeloid leukemia.","volume":"18","author":"Mitelman","year":"1976","journal-title":"Int J Cancer"},{"issue":"suppl 1","key":"2019111904310898400_B3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/10428199309047856","article-title":"The cytogenetic scenario of chronic myeloid leukemia.","volume":"11","author":"Mitelman","year":"1993","journal-title":"Leuk Lymphoma"},{"issue":"26","key":"2019111904310898400_B4","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1182\/blood-2011-08-373902","article-title":"Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.","volume":"118","author":"Fabarius","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2019111904310898400_B5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood-2011-10-384651","article-title":"Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis [published correction appears in Blood. 2013;121(26):5259].","volume":"120","author":"Luatti","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2019111904310898400_B6","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2019111904310898400_B7","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/cncr.21756","article-title":"Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal.","volume":"106","author":"Cortes","year":"2006","journal-title":"Cancer"},{"issue":"14","key":"2019111904310898400_B8","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2015-05-646489","article-title":"Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors.","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/22\/2661\/1393112\/2661.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/22\/2661\/1393112\/2661.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T09:32:07Z","timestamp":1574155927000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/127\/22\/2661\/35114\/Cytogenetics-in-CML-more-important-than-you-think"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":8,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2016,6,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-04-708206","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]}}}